Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy

Affiliations

¹ Mater Research Institute, University of Queensland , Brisbane, QLD , Australia ; School of Medicine, University of Queensland , Brisbane, QLD , Australia ; Centre for Biomedical Research, Burnet Institute , Melbourne, VIC , Australia.
² Centre for Biomedical Research, Burnet Institute , Melbourne, VIC , Australia ; Department of Immunology, Monash University , Melbourne, VIC , Australia.
³ Mater Research Institute, University of Queensland , Brisbane, QLD , Australia ; School of Biomedical Sciences, University of Queensland , Brisbane, QLD , Australia.

Review

Kirsteen M Tullett et al. Front Immunol. 2014.

. 2014 May 22:5:239.

doi: 10.3389/fimmu.2014.00239. eCollection 2014.

¹ Mater Research Institute, University of Queensland , Brisbane, QLD , Australia ; School of Medicine, University of Queensland , Brisbane, QLD , Australia ; Centre for Biomedical Research, Burnet Institute , Melbourne, VIC , Australia.
² Centre for Biomedical Research, Burnet Institute , Melbourne, VIC , Australia ; Department of Immunology, Monash University , Melbourne, VIC , Australia.
³ Mater Research Institute, University of Queensland , Brisbane, QLD , Australia ; School of Biomedical Sciences, University of Queensland , Brisbane, QLD , Australia.

No abstract available

Keywords: Clec9A; DC targeting; XCR1; cross-presentation; dendritic cells; immunotherapy.

References

1. Radford KJ, Tullett KM, Lahoud MH. Dendritic cells and cancer immunotherapy. Curr Opin Immunol (2014) 27C:26–3210.1016/j.coi.2014.01.005 - DOI - PubMed
1. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 31:563–60410.1146/annurev-immunol-020711-074950 - DOI - PMC - PubMed
1. Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood (2008) 112(8):3264–7310.1182/blood-2008-05-155176 - DOI - PMC - PubMed
1. Sancho D, Mourao-Sa D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest (2008) 118(6):2098–11010.1172/JCI34584 - DOI - PMC - PubMed
1. Dorner BG, Dorner MB, Zhou X, Opitz C, Mora A, Guttler S, et al. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity (2009) 31(5):823–3310.1016/j.immuni.2009.08.027 - DOI - PubMed